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Key points
 Calcium ion influx throughN-methyl-D-aspartate receptors (NMDARs)may contribute to sub-
stantia nigra pars compacta (SNc) dopaminergic neurone dysfunction in Parkinson’s disease.
 Responses of NMDARs in dopaminergic neurones showed use-dependent run-down that was
not readily reversible and was partly dependent on Ca2+ influx and partly dependent on
clathrin-mediated endocytosis.
 Thus, we report regulation of NMDARs in SNc dopaminergic neurones by intracellular Ca2+
at both synaptic and extrasynaptic sites and provide evidence for activity-dependent changes
in receptor trafficking.
Abstract N-Methyl-D-aspartate receptors (NMDARs) are Ca2+-permeable glutamate receptors
that play a critical role in synaptic plasticity and promoting cell survival. However, overactive
NMDARs can trigger cell death signalling pathways and have been implicated in substantia nigra
pars compacta (SNc) pathology in Parkinson’s disease. Calcium ion influx through NMDARs
recruits Ca2+-dependent proteins that can regulate NMDAR activity. The surface density of
NMDARs can also be regulated dynamically in response to receptor activity via Ca2+-independent
mechanisms. We have investigated the activity-dependent regulation of NMDARs in SNc
dopaminergic neurones. Repeated whole-cell agonist applications resulted in a decline in the
amplitude of NMDAR currents (current run-down) that was use dependent and not readily
reversible. Run-down was reduced by increasing intracellular Ca2+ buffering or by reducing
Ca2+ influx but did not appear to be mediated by the same regulatory proteins that cause
Ca2+-dependent run-down in hippocampal neurones. The NMDAR current run-down may
be mediated in part by a Ca2+-independent mechanism, because intracellular dialysis with a
dynamin-inhibitory peptide reduced run-down, suggesting a role for clathrin-mediated end-
ocytosis in the regulationof the surfacedensityof receptors. SynapticNMDARswere also subject to
current run-down during repeated low-frequency synaptic stimulation in a Ca2+-dependent but
dynamin-independent manner. Thus, we report, for the first time, regulation of NMDARs in SNc
dopaminergic neurones by changes in intracellular Ca2+ at both synaptic and extrasynaptic sites
and provide evidence for activity-dependent changes in receptor trafficking. These mechanisms
may contribute to intracellular Ca2+ homeostasis in dopaminergic neurones by limiting Ca2+
influx through the NMDAR.
(Resubmitted 24 October 2013; accepted after revision 13 December 2013; first published online 16 December 2013)
Corresponding authors A. J Gibb: Department of Neuroscience, Physiology and Pharmacology, University College
London, Gower Street, London WC1E 6BT, UK. Email: uckldag@yahoo.co.uk
S. Jones:Department of Physiology,Development&Neuroscience,University ofCambridge,Downing Street,Cambridge
CB2 9JR, UK. Email: sj251@cam.ac.uk
Abbreviations AP5, D-2-amino-5-phosphonovaleric acid; BAPTA, 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-
tetraacetic acid; CaM, calmodulin; DA, Dopaminergic; DNQX, 6,7-dinitro-quinoxaline-2,3-dione; EGTA, Ethylene
glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid; EPSC, excitatory post synaptic current; GA, GABAergic;
GluN2A, NMDA receptor subunit type 2A; GluN2B, NMDA receptor subunit type 2B; GluN2C, NMDA receptor sub-
unit type 2C; GluN2D, NMDA receptor subunit type 2D; Ih, hyperpolarization-activated inward current; INMDA, NMDA
activated current; MLCK, myosin light chain kinase; NMDAR, N-methyl-D-aspartate receptor; SNc, substantia nigra
pars compacta; SNr, substantia nigra pars reticulata.; WCR, Whole cell recording
C© 2013 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society. DOI: 10.1113/jphysiol.2013.267310
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution
and reproduction in any medium, provided the original work is properly cited.
654 A. R. Wild and others J Physiol 592.4
Introduction
Dopaminergic neurones of the substantia nigra pars
compacta (SNc) are critically involved in the selection and
learning of voluntary motor behaviour (Groenewegen,
2003; Morikawa & Paladini, 2011). The degeneration
and loss of these neurones gives rise to severe motor
impairment and disability, which are defining features
of Parkinson’s disease (Braak et al. 2003; Obeso et
al. 2010; Surmeier et al. 2010). While the origins of
the neuronal pathology underlying Parkinson’s disease
are not yet clear, dysregulated Ca2+ and mitochondrial
dysfunction may have a prominent role (Surmeier et al.
2010, 2011). Elevated intracellular [Ca2+] can activate
signalling pathways coupled to cell death (Hardingham
& Bading, 2010; Surmeier et al. 2010), has a detrimental
effect onmitochondrial function (Duchen et al. 2008) and
enhances the toxic effects of a high cytosolic dopamine
concentration (Mosharov et al. 2009). Through one or
more of these mechanisms, perturbations in Ca2+ homo-
eostasis may contribute to nigrostriatal degeneration.
One source of Ca2+ influx is through
N-methyl-D-aspartate receptors (NMDARs). Over-
activity of NMDARs and resultant elevated intracellular
[Ca2+] can lead to neuronal excitotoxicity (Rothman
& Olney, 1986; Choi, 1987; Hardingham & Bading,
2010) and has been implicated in the pathogenesis of
Parkinson’s disease (Sonsalla et al. 1998; Blandini et al.
2000), and NMDA reduces dopamine cell density in SNc
(Wild et al. 2013). Nigrostriatal degeneration also results
in increased glutamatergic output from the subthalamic
nucleus to the SNc (Blandini et al. 2000; Hamani et al.
2004). Convergence of enhanced glutamatergic input
with pathologically potentiated NMDAR activity might
elevate intracellular [Ca2+] beyond homeostatic control
(Blandini et al. 2000; Surmeier et al. 2011).
The NMDARs are themselves regulated by an array
of Ca2+-dependent and Ca2+-independent proteins
(Dingledine et al. 1999; Nong et al. 2003; Salter et al.
2009; Traynelis et al. 2010) that control the sensitivity of
neurones to glutamate, shape synapticNMDARresponses,
impact on synaptic plasticity mechanisms and potentially
regulate excitotoxicity (Tong et al. 1995; Sprengel et al.
1998; Hashimoto et al. 2002; Sessoms-Sikes et al. 2005).
The extent to which these mechanisms operate in SNc
dopaminergicneurones isnot known,despite thepotential
clinical implications of dysregulated Ca2+ influx.
The purpose of this study was to investigate
mechanisms of activity-dependent regulation of
NMDARs in dopaminergic neurones. NMDARs
activated by whole-cell applications of NMDA were
negatively regulated by Ca2+ influx through NMDARs
in an activity-dependent manner. However, this
Ca2+-dependent run-down was not attenuated by intra-
cellular dialysis with a calmodulin-inhibitory peptide
or inhibitors of calcineurin or actin depolymerization,
three Ca2+-dependent mechanisms important in cortical
and hippocampal neurones. The NMDARs found in
SNc dopaminergic neurones were less sensitive to
Ca2+-dependent run-down than NMDARs found on
neighbouring non-dopaminergic neurones. Run-down
of whole-cell NMDAR responses was attenuated by a
dynamin-inhibitory peptide, suggesting that run-down
is partly dependent on receptor trafficking. During
repetitive synaptic stimulation, the amplitude of synaptic
NMDAR EPSCs in dopaminergic neurones decreased in
a Ca2+-dependent but dynamin-independent manner.
Thus, both synaptic and extrasynaptic NMDARs in
SNc dopaminergic neurones show robust and, in some
aspects, distinct activity-dependent self-regulation. These
mechanisms could be important in Ca2+ homeostasis in
dopaminergic neurones.
Methods
Brain slice preparation
Sprague–Dawley or Wistar rats (aged 5–8 days post-
natal) were deeply anaesthetized with isofluorane or
halothane and/or decapitated in accordance with the UK
Animals (ScientificProcedures)Act 1986 andLocal Ethical
Committee approval. One hundred and fifteen rats were
used in this study. The brain was removed into ice-cold
oxygenated slicing solution containing (mM): sucrose, 100;
NaCl, 62.5; KCl, 2.5; CaCl2, 1; MgCl2, 4; NaHCO3, 25;
NaH2PO4, 1.25; 0.1mMkynurenic acid and glucose, 25; of
pH7.4when saturatedwith 95%O2 and 5%CO2. Coronal
or horizontal brain slices (300 μm thick) were prepared
using a vibrating microslicer (Dosaka, Japan or Leica,
Germany). Slices containing themidbrain substantia nigra
region were kept in oxygenated solution containing (mM):
NaCl, 125; KCl, 2.5; CaCl2, 1; MgCl2, 4; NaHCO3, 25;
NaH2PO4, 1.25; and glucose, 25 for 1–6 h before use.
Whole-cell recordings from substantia nigra neurones
Slices were placed in a recording chamber on the stage
of an upright microscope with Nomarski differential
interference contrast optics. During whole-cell current
recordings, coronal slices were continuously bathed
in the same solution used for storing the slices,
without added MgCl2 and with bicuculline (10 μM),
strychnine (10 μM) and tetrodotoxin (100 nM; from
Ascent Scientific) at room temperature (22–24°C).
Synaptic currents were recorded from horizontal slices
in 6,7-dinitro-quinoxaline-2,3-dione (DNQX; 10 μM),
picrotoxin (50 μM) and with 0.1 or 1.3 mM MgCl2
at 30 ± 2°C. Patch pipettes were made from
borosilicate glass to a final resistance of 2–6 M
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when filled with solution containing (mM): CsCl, 140;
Hepes, 10; NaCl, 10; CaCl2, 0.5; MgCl2, 0.5–1.0;
and CsOH, 29.53; pH 7.2, with Na2ATP, 2; NaGTP,
0.3 (all from Sigma); and Ca2+ chelators (EGTA
or BAPTA) or other additions as specified in the
text. Free Ca2+ was calculated using WinMAXC32.exe
(http://maxchelator.stanford.edu/downloads.htm).
Recordings were made from visually identified
neurones in the SNc (unless otherwise noted),
identified based on the presence of a time-dependent,
hyperpolarization-activated inward current (Ih) of more
than 50 pA in response to a voltage step from −60
to −110 mV (Washio et al. 1999; Neuhoff et al. 2002;
Margolis et al. 2006). Over 90% of neurones in the rat
SNc are dopaminergic (Fallon & Loughlin, 1995). Neuro-
nes in the nearby substantia nigra pars reticulata (SNr)
were recorded in some experiments; these are primarily
GABAergic projection neurons.
Cells were voltage clamped to −60 or +40 mV
as specified in the text, and whole-cell currents or
synaptic currents were recorded using an Axopatch 200B
patch-clamp amplifier (Axon Instruments, USA), filtered
at 2 kHz and digitized at 10 kHz using a Micro 1401
interface (Cambridge ElectronicDesign,Cambridge,UK).
Cell membrane capacitance and series resistance were
estimated using the series resistance compensation circuit
of the Axopatch 200B (series resistance was compensated
by 40–80%) and checked throughout the experiment
for stability. Whole-cell NMDA currents were evoked by
adding NMDA (200 μM; Sigma) and glycine (10 μM;
Sigma) by switching to agonist solution for 15 s using
a solenoid valve system (c-Flow; Cell MicroControls,
Norfolk,VA,USA) to regulate solutionflow to a theta-glass
applicator placed 1 mm above the surface of the slice.
These responses had 10–90% rise times of 3–5 s (Sua´rez
et al. 2010). Synaptic currents were evoked using a bipolar
stainless-steel electrode (Frederick Haer and Co., USA)
and stimuli (100 μs duration; amplitude 60–250 μA)
applied at 10 s intervals.
Electrophysiological measurements
Whole-cell NMDA currents were acquired and analysed
using WinEDR version 2.5.9 software (Dempster, 2001;
version2.2.3 available at http://spider.science.strath.ac.uk/
PhysPharm/showPage.php?pageName=software_ses).
Synaptic currents were acquired and analysed using
Spike2 (version 4) software (Cambridge Electronic
Design, Cambridge, UK). To quantify run-down in
responses to consecutive agonist applications in the
different conditions tested, the decrease in peak INMDA
between the first and nth NMDA application was
measured. To quantify run-down of synaptic NMDAR
responses over comparable time scales to agonist-evoked
responses, nine responses to synaptic stimulation (given
every 10 s) were averaged (e.g. ‘time 0 s’ is the average
of nine responses from 0 to 90 s) and the decrease in
mean peak NMDA-EPSC amplitude between the first
and fifth time point at 400 s was measured. Data are
expressed as means ± SEM; the ‘n’ values refer to the
number of slices. For all data sets, normality was tested
using the Kolmogorov–Smirnoff test (GraphPad Prism
version 4). For comparisons of two groups of data,
Student’s t test was used (with Welch’s correction if
variance between the groups was different) and for more
than two groups of data ANOVA followed by Bonferroni
multiple comparisons test was used.
Results
NMDARs in SNc dopaminergic neurones show
activity-dependent run-down
The NMDAR-mediated whole-cell responses show
run-down with repeated applications of NMDA to SNc
dopaminergic neurones (Sua´rez et al. 2010). In order to
investigate regulatory mechanisms that might mediate
this effect, NMDA (200 μM, with 10 μM glycine, for
15 s) was applied repeatedly every 100 s. As illustrated
in Fig. 1A, in dopaminergic neurones voltage clamped to
−60 mV and with 10 mM BAPTA in the pipette solution,
following an initial application of NMDA, there was a
subsequent decline in peak current with each successive
application, which we define here as current ‘run-down’.
Thefirst response toNMDA(It0)hadanaverage amplitude
of −4334 ± 296 pA, while the fifth response (It400)
was significantly less and averaged −2558 ± 235 pA
(P < 0.0001, Student’s paired t test, n = 16; Fig. 1B). The
It400/It0 ratio, used to quantify the extent of run-down, was
0.59 ± 0.03 (Fig. 1E). To determine whether the observed
run-down was activity dependent, in a separate group of
neurones NMDA was applied every 400 s (Fig. 1C). In
these cells, It400 was not significantly different from It0
(Fig. 1D and E; P = 0.22, Student’s paired t test, n = 8),
with a ratio of 1.17 ± 0.09. Significantly more run-down
was seen at It400 whenNMDAwas applied every 100 s than
when applied every 400 s (Fig. 1E; P < 0.006, Student’s
unpaired t test with Welch’s correction), suggesting that
repeated receptor activation or current through the
receptor channel leads to run-down.
Modifications to NMDARs that may mediate current
run-down in dopaminergic neurones, such as changes
in receptor phosphorylation or association of regulatory
proteins, can be transient; therefore, we tested the ability
of NMDARs in dopaminergic neurones to recover from
run-down. Following five repeated applications of NMDA
every 100 s, a pause of 300 s was allowed (Fig. 1F and
G) to determine whether recovery from run-down would
occur. Therewas a small but significant decrease in current
C© 2013 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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amplitude at 700 s (−2721± 491 pA) comparedwith 400 s
(−3076 ± 419; n = 7; P = 0.0114, Student’s paired t test),
indicating that the run-down persists and is not readily
reversible in these whole-cell recording conditions.
Run-down of whole-cell NMDAR responses
is in part Ca2+ dependent
Calcium-dependent run-down is a well-established form
of NMDAR regulation (Legendre et al. 1993; Rosenmund
& Westbrook, 1993a,b; Tong & Jahr, 1994; Ehlers
et al. 1996; Medina et al. 1996; Rycroft & Gibb, 2002);
therefore, a series of experiments was designed to assess
the dependence ofNMDAR current run-down on changes
in intracellular Ca2+ concentration. First, two different
Ca2+ buffers were compared to investigate the effect
that sequestering intracellular Ca2+ would have on the
amplitudes of NMDAR responses. A high concentration
of fast Ca2+ buffer (10 mM BAPTA, estimated free Ca2+
20 nM) was compared with a low concentration of slow
Figure 1. Repeated agonist applications induce N-methyl-D-aspartate receptor (NMDAR) current
run-down that is not readily reversible
A, representative current trace showing responses to repeated brief applications of 200 μM NMDA (glycine, 10 μM)
applied every 100 s. B, graph comparing current amplitudes after one NMDA application (It0) with those after
five applications (It400) from 16 experiments as in A (∗∗∗P < 0.001, Student’s paired t test). C, example current
trace as in A but with NMDA applications every 400 s. D, comparison of current amplitudes after one NMDA
application (It0) with those after two applications (It400) from eight experiments as in C. E, ratio of It400/It0 for
NMDA applications every 100 and every 400 s (∗∗P = 0.006, Student’s unpaired t test with Welch’s correction).
F, representative current trace showing responses to 200 μM NMDA (glycine, 10 μM) applied every 100 s, then
after 300 s G, paired current amplitudes after five NMDA applications (It400) and those after six applications (It700)
from seven experiments as in F (∗P < 0.05, Student’s paired t test). All experiments were performed at a holding
potential of –60 mV with 10 mM BAPTA in the pipette solution.
C© 2013 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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Ca2+ buffer (0.6mMEGTA, estimated freeCa2+735nM).
Changing the Ca2+ chelator in the intracellular solution
from 10 mM BAPTA (e.g. Fig. 1A) to 0.6 mM EGTA (e.g.
Fig. 2A) had no effect on the initial current amplitude
(It0 = −4644 ± 462 pA, n = 17 in 0.6 mM EGTA;
Supporting information Table S1)but resulted in more
run-down (It400/It0) in dopaminergic neurones voltage
clamped to−60mV(EGTA, It400/It0 = 0.37± 0.02,n= 15;
BAPTA, 0.59 ± 0.03, n = 16; P < 0.001, ANOVA with
Bonferroni multiple comparisons test; Fig. 2B and C).
To determine whether this Ca2+ dependence
was NMDAR subunit dependent, the experiments
were repeated following incubation with the
GluN2B-preferring antagonist, ifenprodil (10 μM;
minimal incubation time, 30 min). Interestingly,
run-down was not significantly different between
Figure 2. Whole-cell NMDAR current run-down is in part Ca2+ dependent
A, responses to repeated brief applications of 200 μM NMDA (glycine, 10 μM) applied every 100 s with 0.6 mM
EGTA in the pipette solution. B, time course of NMDA current run-down with either 0.6 mM EGTA or 10 mM BAPTA
in the pipette solution. Current amplitudes are normalized to the amplitude of the first response. C, ratio of It400/It0
with 0.6 mM EGTA or 10 mM BAPTA in the pipette solution for the full component and for the ifenprodil-insensitive
component (∗∗∗P < 0.001, ANOVA with Bonferroni multiple comparisons test). D, as in A, but with 10 mM BAPTA
in the pipette solution and extracellular Ca2+ replaced with equimolar Ba2+. E, time course of NMDA current
run-down with 10 mM BAPTA in the pipette solution at –60 mV, extracellular divalent cation substitution with
Ba2+ at –60 mV or with Ca2+ at +40 mV. Current amplitudes are normalized to the average amplitude of the first
response. F, ratio of It400/It0 with 10 mM BAPTA in the pipette solution, at –60 mV with extracellular divalent cation
either Ca2+ or Ba2+ (a) and with membrane potential clamped to –60 or to +40 mV (b; ∗P = 0.025; ∗∗P < 0.003,
ANOVA with Bonferroni multiple comparisons test).
C© 2013 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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Figure 3. Repeated stimulation of synaptic NMDARs at
–50 mV induces current run-down
A, representative NMDAR EPSCs recorded from a single
dopaminergic neurone evoked by synaptic stimulation at 0.1 Hz in
the presence of 6,7-dinitro-quinoxaline-2,3-dione (DNQX, 10 μM),
glycine (10 μM), picrotoxin (50 μM) and Mg2+ (0.1 mM) at +40 mV
with 10 mM BAPTA in the pipette solution. Inset traces are the
BAPTA (0.59 ± 0.05, n = 7) and EGTA (0.67 ± 0.08,
n = 7; P > 0.05, ANOVA with Bonferroni multiple
comparisons test; Fig. 2C), suggesting that run-down of
the non-GluN2B component is not Ca2+ dependent.
Potential sources of Ca2+ that could induce current
run-down are that which has fluxed through the channel
pore or that which has been released from intracellular
stores (e.g. by Ca2+-induced Ca2+ release). Extracellular
Ca2+ was replaced with equimolar Ba2+ (e.g. Fig. 2D).
With 10 mM BAPTA in the pipette, following substitution
of extracellular Ca2+ with Ba2+ there was still significant
run-down (It400/It0 = 0.70 ± 0.04, n = 10; P = 0.0054,
Student’s paired t test) but significantly less than that
seen with 1 mM extracellular Ca2+ (P = 0.025, Student’s
unpaired t test; Fig. 2E and F).
The driving force for Ca2+ moving into the cell was
reduced by voltage clamping the neurone at +40 mV. At
+40 mV (with 10 mM BAPTA in the pipette solution),
there was no significant change in peak current between
the first and fifth response (average amplitude of first
response, 3911 ± 431 pA, Table S1; P = 0.0581, Student’s
paired t test) and the It400/It0 ratio (0.85 ± 0.06, n = 7)
was significantly different from that seen at −60 mV
(P = 0.0026, Student’s unpaired t test; Fig. 2E and F).
Thus, the amount of current through active NMDARs in
dopaminergic neurones is regulated by intracellular Ca2+
and is sensitive to the amount of Ca2+ influx through the
NMDAR channel.
Regulation of synaptic NMDARs by Ca2+
Changes in intracellular Ca2+ can also affect the amplitude
of NMDA EPSCs over time, because synaptic NMDARs
are also regulated in a Ca2+-dependent manner (Tong
et al. 1995; Medina et al. 1999; Umemiya et al. 2001).
In dopaminergic neurones voltage clamped to +40 mV,
the initial NMDA-EPSC responses to evoked glutamate
release (It0) had an average amplitude of 50.2 ± 7.8 pA
(10 mM BAPTA) or 59.6 ± 10.3 pA (0.6 mM EGTA).
The NMDA EPSCs showed a small but significant degree
of run-down at +40 mV (e.g. 10 mM BAPTA It400/It0,
average of 10 EPSCs recorded between 0 and 90 s (black) or
between 400 and 490 s (grey). B, NMDAR EPSCs evoked by synaptic
stimulation as in A but at −50 mV (with 10 mM BAPTA). C, graph
showing changes in NMDAR-EPSC amplitude over time at +40 mV
(circles) and −50 mV (squares), with either 0.6 mM EGTA (white
symbols) or 10 mM BAPTA (black symbols) in the pipette. Each time
point represents the average of 10 EPSCs and is normalized to the
average amplitude of the first 10 responses. D, ratio of It400/It0 with
10 mM BAPTA or 0.6 mM EGTA in the pipette solution, at either +40
or −50 mV, with the latter including ifenprodil-insensitive NMDA
EPSCs (∗P < 0.05, ANOVA with Bonferroni multiple comparisons
test). The It0 is the average of 10 EPSCs between 0 and 90 s, while
the It400 is the average of 10 responses between 400 and 490 s.
C© 2013 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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0.86 ± 0.06, n = 10; P = 0.0344, Student’s paired t test;
Fig. 3A). Run-down wasmoremarked at−50mV (10mM
BAPTA: initial NMDA-EPSC amplitude, −66.6 ± 7.5 pA;
It400/It0, 0.58 ± 0.05, n = 10; P < 0.0001, Student’s
paired t test; Fig. 3B). Run-down of NMDA EPSCs was
not significantly different from run-down of whole-cell
responses to NMDA at +40 mV (P = 0.948, Student’s
unpaired t test) or−60mV (P= 0.974, Student’s unpaired
t test) with 10 mM BAPTA in the pipette. However,
synaptic NMDARs showed no sensitivity to intracellular
Ca2+ buffering; at −50 mV, with 0.6 mM EGTA, initial
NMDA-EPSC amplitude was −54.2 ± 7.1 pA and It400/It0
was 0.67± 0.08 (n= 8; P= 0.0086, Student’s paired t test),
not significantly different from It400/It0 for 10 mM BAPTA
at −50 mV (P > 0.05, ANOVA with Bonferroni multiple
comparisons test; Fig. 3C and D).
To determine whether NMDA-EPSC run-down at
−50 mV was subunit dependent, the experiments
were repeated following incubation with the
GluN2B-preferring antagonist, ifenprodil (10 μM;
minimal incubation time, 30 min). Run-down was
not significantly different following incubation in the
presence of ifenprodil (0.59 ± 0.05, n = 7; P > 0.05,
ANOVA with Bonferroni multiple comparisons test;
Fig. 3D).
Differences in NMDAR regulation between
dopaminergic and GABAergic neurones
Dopaminergic neurones of the substantia nigra are more
vulnerable to cell death than neighbouring GABAergic
neurones in Parkinson’s disease (Braak et al. 2003).
Dysregulated Ca2+ homeostasis, including differences
in regulation of NMDAR-mediated Ca2+ influx, may
contribute to this selective vulnerability. Therefore, we
next compared the degree of NMDAR run-down in
dopaminergic neurones (e.g. Figs 1A and 4B) with
that in GABAergic neurones (e.g. Fig. 4A and B)
with the two levels of intracellular Ca2+ buffering.
There was no significant difference in the initial
amplitudes in GABAergic neurones compared with
dopaminergic neurones with either BAPTA or EGTA
(P = 0.66 and P = 0.29, respectively). However,
there was significantly more whole-cell NMDAR current
run-down in GABAergic neurones (Fig. 4C) with BAPTA
(0.45 ± 0.05, n = 9, P < 0.05), but not with EGTA in
the intracellular solution, compared with dopaminergic
neurones (ANOVAwithBonferronimultiple comparisons
test). Run-down of synaptic NMDARs in response to
glutamate release at−50mVwasnot significantly different
between the twoneuronal populationswith either chelator
(ANOVA with Bonferroni multiple comparisons test).
Run-down of whole-cell and synaptic NMDARs in
dopaminergic versus GABAergic neurones is summarized
in Fig. 4C.
NMDAR current run-down is not reversed by a
calmodulin-inhibitory peptide
It is well established in hippocampal neurones that
Ca2+–calmodulin (Ca2+–CaM) binding to the GluN1
subunit C-terminal domain can induce Ca2+-dependent
inactivation of NMDARs (Ehlers et al. 1996; Zhang
et al. 1998; Rycroft & Gibb, 2002). To determine
whether the Ca2+-dependent run-down in dopaminergic
neurones was mediated by Ca2+–CaM, the protocol
was repeated but with either a CaM-inhibitory
Figure 4. NMDAR current run-down is greater in GABAergic
neurones than in dopaminergic neurones
A, responses to repeated brief applications of 200 μM NMDA
(glycine, 10 μM) applied every 100 s with 10 mM BAPTA in the
pipette solution, from a GABAergic neurone. B, time course of
NMDAR current run-down with 10 mM BAPTA in the pipette solution
for dopaminergic (DA) and GABAergic neurones (GA). Current
amplitudes were normalized to the amplitude of the first response
(DA, −4334 ± 296 pA; and GA, −4177 ± 681 pA). C, ratio of
It400/It0 for whole-cell recordings (WCR) and NMDAR EPSCs
(∗P < 0.05, ANOVA with Bonferroni multiple comparisons test).
C© 2013 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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peptide, based on the CaM-binding domain of MLCK
(RRKWQKTGHAVRAIGRL, 50 μM; Calbiochem), or a
control peptide with several amino acid substitutions
(RRKEEKTGHAVRAIGRE, 50μM;Calbiochem) included
in the pipette solution. With 0.6 mM EGTA in the pipette
solution (to optimize activation of Ca2+–CaM), there
was no difference in the extent of whole-cell run-down
between inhibitory (It400/It0 = 0.39 ± 0.02, n = 8) and
control peptide (It400/It0 = 0.35 ± 0.03, n = 8; P = 0.37,
Student’s unpaired t test; Table S1). To ensure that slow
dialysis was not preventing the peptide from reaching
its target, the experiments were repeated but with a
20 min wait in whole-cell recording mode prior to the
first NMDA application. Again, no significant differences
were observed (Table S1).
Calcineurin is a Ca2+-dependent protein phosphatase
that regulates NMDAR function (Tong et al. 1995; Krupp
et al. 2002; Rycroft & Gibb, 2004b). Inclusion of the
calcineurin inhibitor ciclosporin (500 nM) in the pipette
solution with 0.6 mM EGTA had no significant effect on
current run-down when compared with 0.6 mM EGTA
alone (Table S1).
The NMDA current run-down in hippocampal
neurones in culture involves actin depolymerization
(Rosenmund & Westbrook, 1993a); therefore, run-down
was tested in the presence of phalloidin (10 μM).
Phalloidin was unable to reduce run-down (Table S1).
These results do not support a role for CaM, calcineurin
or actin depolymerization in mediating Ca2+-dependent
run-down in substantia nigra dopaminergic neurones
and suggest that different Ca2+-dependent NMDAR
regulatory mechanisms operate compared with those
reported in hippocampal neurones.
Dynamin-dependent regulation
In hippocampal neurones, agonist binding can lead
to activity-dependent changes in NMDAR trafficking,
whereby receptors are internalized (Vissel et al. 2001;
Li et al. 2002). A well-established form of NMDAR
internalization is through clathrin-mediated endocytosis
(Lavezzari et al. 2003), a process which is dependent on the
GTPase dynamin but not onCa2+ (Vissel et al. 2001; Nong
et al. 2003; Montgomery et al. 2005). This has not been
tested in dopaminergic neurones. As shown in Fig. 2, when
elevations in intracellular Ca2+ wereminimized by voltage
clamping to +40 mV or replacing extracellular Ca2+
with Ba2+ and chelating intracellular Ca2+ with 10 mM
BAPTA, a use-dependent decline in peak current was still
observed (Fig. 2E). To test whether this run-down might
be dynamin dependent, a dynamin-inhibitory peptide
(QVPSRPNRAP; 50μM; Tocris) was included in the intra-
cellular solution, along with 10mMBAPTA. Recordings of
whole-cell NMDAR currents at +40 mV using a control
peptide (QPPASNPRVR; 50 μM; Tocris; e.g. Fig. 5A)
showed significant run-down (It400/It0, 0.80± 0.05; n= 8;
P = 0.004, Student’s paired t test), but no significant
run-down was observed when using dynamin-inhibitory
peptide (e.g. Fig. 5B; It400/It0, 1.04± 0.07,n= 10;P= 0.65,
Student’s paired t test; Fig. 5C and D). A significant
difference in run-downwas observed between control and
dynamin peptides (Fig. 5C andTable S1;P< 0.05, ANOVA
with Bonferroni multiple comparisons test).
The NMDARs are internalized via clathrin-coated
pits, which in hippocampal neurones are located peri-
or extrasynaptically (Petralia et al. 2003; Newpher
& Ehlers, 2009). It has been reported that synaptic
NMDARs are more stable within the cell membrane
than their extrasynaptic counterparts and less sensitive to
use-dependent internalization (Li et al. 2002). In order
to assess the stability of NMDARs at synaptic sites in
dopaminergic neurones, NMDAREPSCswere recorded at
+40mV.No significant run-downwasdetectedwith either
peptide, and there was no significant difference between
control and dynamin-inhibitory peptide (P = 0.72,
Student’s unpaired t test; Fig. 5E and Table S1). Although
intracellular calcium dynamics are likely to be different
between whole-cell and synaptic receptor activation
protocols, these results suggest that during localized
activation, synapticNMDARsundergo less internalization
by clathrin-mediated (dynamin-dependent) endocytosis
than their extrasynaptic counterparts.
Can agonist binding induce receptor modulation
independent of ion flux?
Agonist binding can lead to modulation of the receptor
response even in the absence of ion flux through the
channel (Vissel et al. 2001). To determine whether this
mechanism contributes to run-down in dopaminergic
neurones, NMDA applications were made in conditions
where ion flux through the NMDAR channel was blocked.
As illustrated in Fig. 6B, an initial responsewas recorded in
Mg2+-free solution at +40 mV followed by three agonist
applications at −60 mV in the presence of 10 mM Mg2+.
A test response was then recorded at +40 mV and the
amplitude compared with the initial response. In these
conditions, there was no significant run-down (It400/It0,
0.95 ± 0.07; n = 12; P = 0.1844). However, when no
agonist was applied between the initial and test responses
in the same conditions (e.g. Fig. 6A) the It400/It0 was
significantly greater (1.20 ± 0.10; n = 9; P = 0.041,
Student’s unpaired t test; Fig. 6C), suggesting that agonist
binding might trigger some run-down independently of
ionic flux.
In rat hippocampal slices, a prolonged application
of a high concentration of glycine to neurones can
induce a robust decrease in NMDAR currents when
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receptors are subsequently activated with both NMDA
and glycine (Nong et al. 2003). Glycine binding alone was
found to be sufficient to produce an intracellular signal,
‘priming’ NMDARs for clathrin-mediated internalization
(Nong et al. 2003). Here, a prolonged application of
a high concentration of glycine (100 μM for 200 s)
between receptor activation at It0 and It400 was used as a
priming conditioning stimulus in an attempt to promote a
more robust internalization of NMDARs in dopaminergic
neurones (e.g. Fig. 6E). As a control, the glutamate binding
site competitive NMDAR antagonist AP5 (30 μM) was
applied instead of glycine (e.g. Fig. 6D). When glycine
was used as the conditioning stimulus, the It400/It0 ratio
(1.31 ± 0.10, n = 8) was not significantly different
from that seen in the presence of AP5 (1.12 ± 0.10,
n = 7; ANOVA; Fig. 6F). These results suggest that
Figure 5. Run-down at +40 mV is prevented by inclusion of a dynamin-inhibitory peptide in whole-cell
but not synaptic recordings
A, responses to repeated brief applications of 200 μM NMDA (glycine, 10 μM) applied every 100 s with 10 mM
BAPTA and scrambled peptide (50 μM) or dynamin-inhibitory peptide (50 μM) in the pipette solution as indicated,
from a neurone voltage clamped at +40 mV. B, time course of NMDAR current run-down with 10 mM BAPTA and
either control peptide (ConP) or dynamin-inhibitory peptide (DIP) in the pipette solution. Current amplitudes were
normalized to the amplitude of the first response. C, ratio of It400/It0 for NMDA applications every 100 s with
no peptide (NoP), ConP or DIP in the pipette solution (∗P < 0.05, ANOVA with Bonferroni multiple comparisons
test). D, representative current trace of NMDAR EPSCs evoked by synaptic stimulation at 0.1 Hz in the presence of
DNQX (10 μM), glycine (10 μM) and picrotoxin (50 μM). Responses were recorded at +40 mV with 10 mM BAPTA
and control peptide (50 μM) or dynamin-inhibitory peptide (50 μM) in the pipette solution, as indicated. Traces
are the average of 10 EPSCs. In black is the average of responses between 0 and 90 s. In grey is the average of
responses between 400 and 490 s. E, changes in NMDAR-EPSC amplitude over time. Each time point represents
the average of 10 EPSCs and is normalized to the average amplitude of the first response.
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glycine priming was unable to cause an immediate decline
in INMDA upon NMDA application, a finding that is in
agreement with the results of Nong et al. (2003). In order
to address whether glycine priming accelerates any sub-
sequent decline in INMDA, NMDA applications were made
at 100 s intervals following measurement of It400. The
time course of run-down was very similar following either
control (AP5) or glycine as the conditioning stimulus
Figure 6. NMDAR current run-down at +40 mV is independent of ion flux
A, responses to repeated brief agonist applications of NMDA (200 μM; glycine, 10 μM) applied every 400 s, from
a neurone voltage clamped to +40 mV. The slice was perfused with 10 mM Mg2+ at −60 mV between agonist
applications. B, as in A, but with agonist applications made every 100 s during perfusion with 10 mM Mg2+ at
−60 mV. C, ratio of It400/It0 for the control and test protocols described in A and B (∗P = 0.04, Student’s unpaired
t test). D, responses to repeated applications of 200 μM NMDA (glycine 10 μM) from a neurone voltage clamped
to −60 mV. The ‘conditioning stimulus’ was 30 μM AP5, applied for 285 s. E, as in A, but with 100 μM glycine
as the conditioning stimulus. F, ratio of It400/It0 for the control (applications every 400 s, Fig. 1C), 30 μM AP5 and
100 μM glycine groups (not significantly different, ANOVA). G, time course of run-down following the NMDA
application at 400 s for the AP5 (as in Fig. 6D) and glycine groups (as in Fig. 6E). For comparison, the time course
of run-down is also shown for the experiment in which NMDA applications started at 0 s (Fig. 1A). All experiments
were performed with 10 mM BAPTA in the pipette solution.
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(Fig. 6G). The It800/It400 was 0.49 ± 0.09 with control
(AP5) and 0.48 ± 0.05 with glycine (P = 0.1757,
Student’s unpaired t test). These results indicate that,
unlike the situation in hippocampal neurones (Nong
et al. 2003), in SNc dopaminergic neurones glycine
priming was unable to either induce or enhance INMDA
run-down.
Discussion
NMDA receptor current run-down is a form of
activity-dependent NMDAR regulation (Legendre et al.
1993; Rosenmund & Westbrook, 1993a,b; Medina et al.
1996; Zhang et al. 1998). It can involve both changes in
channel open probability and/or changes in the number
of receptors on the cell surface and can control the
contribution of NMDARs to synaptic signalling (Tong
et al. 1995). Run-down might also be regarded as a
protectivemechanismto limit excessiveCa2+ influxduring
periods of high NMDAR activity (Hashimoto et al. 2002)
at synaptic and extrasynaptic locations. The sensitivity
to excitotoxic damage may be determined by a number
of factors, such as the NMDAR subunit profile (Liu
et al. 2007; Martel et al. 2012), the surface localization of
the receptor (Hardingham & Bading, 2010), intracellular
Ca2+ buffering (Rintoul et al. 2001), receptor association
with scaffolding proteins (Forder & Tymianski, 2009) and,
perhaps, activity-dependent receptor regulation. The aim
of the present study was to investigate activity-dependent
NMDAR current run-down in SNc dopaminergic
neurones.
Whole-cell NMDAR current run-down is in part Ca2+
dependent
Regular whole-cell NMDA applications to dopaminergic
neurones induced large whole-cell currents that declined
with each successive agonist application in a similar
way to that described in other studies of NMDARs
in hippocampal neurones (MacDonald et al. 1989;
Rosenmund & Westbrook, 1993a,b). This decline in peak
current, or run-down, occurred only when repeated
agonist applications were made (at 100 s intervals). This
would suggest that run-down is due to receptor activity,
rather than to dialysis of cytosolic components that might
be a result of whole-cell recording or to release of Ca2+
from intracellular stores. Responses that ran down did
not recover when agonist applications were withdrawn
for 5 min, suggesting that in the conditions of whole-cell
patch-clamp recording, the decrease in NMDAR activity
was long lasting rather than transient.
The extent of whole-cell NMDAR current run-down
was increased by reducing intracellular Ca2+ buffering;
NMDAR run-down was greater when neurones were
dialysed with 0.6 mM EGTA (estimated free Ca2+,
735 nM) than with 10 mM BAPTA (estimated free Ca2+,
20 nM). EGTAandBAPTAhave a similar binding affinity
for Ca2+, but markedly different binding kinetics, with
BAPTA being able to sequester Ca2+ in the region of two
orders of magnitude faster than EGTA (Pethig et al. 1989;
Adler et al. 1991). Buffers dialysed into a cell are able to
compete for Ca2+ bindingwith endogenousCa2+-binding
proteins. The difference in run-down observed with the
two buffers in the experiments presented here suggests
that the Ca2+-dependent proteins that regulate NMDAR
run-down indopaminergic neurones are able to bindCa2+
more rapidly than EGTA but less rapidly than BAPTA.
We have previously reported that NMDARs in SNc
dopaminergic neurones are composed of GluN2B and
GluN2D subunits, most probably in a combination of
di- and tri-heteromers (Jones & Gibb, 2005; Brothwell
et al. 2008; Sua´rez et al. 2010). To examine the sub-
unit dependence of run-down, the run-down was
measured after incubation with the GluN2B-preferring
antagonist, ifenprodil. Significant run-down of the
ifenprodil-insensitive NMDAR component was observed,
but showed no sensitivity to intraceullar Ca2+ chelator.
This is consistent with the ifenprodil-insensitive
component being GluN2D mediated, because
GluN2D currents show little desensitization (Wyllie
et al. 1998).
The source ofCa2+ appears to beprimarily extracellular,
because substitution of extracellular Ca2+ with Ba2+ and
reducing the Ca2+ driving force by clamping neurones at
+40 mV both caused a significant reduction in run-down
(Fig. 2). However, a role for Ca2+ release from intra-
cellular stores cannot be excluded. While Ba2+ is able to
permeate theNMDAR channel pore (Mayer&Westbrook,
1987; Ascher & Nowak, 1988), it does not activate
Ca2+-dependent proteins (Chao et al. 1984; Richardt
et al. 1986). Extracellular substitution of Ca2+ with Ba2+ is
known to reduce (but not prevent) NMDAR inactivation
(defined as the decline in peak current observed during
a single application of agonist) in hippocampal neuro-
nes and in transfected HEK 293 cells (Legendre et al.
1993; Krupp et al. 1996) and slow the decay kinetics
of EPSCs in cultured cortical neurones (Umemiya et al.
2001), probably due to a reduction in the kinetic effects of
Ca2+–CaMbinding to the receptor (Rycroft&Gibb, 2002).
Given the prominent role that CaM is known to
play in regulating NMDARs (Rosenmund & Westbrook,
1993a; Ehlers et al. 1996; Krupp et al. 1999; Rycroft
& Gibb, 2002; reviewed by Lisman et al. 2012), it is
perhaps surprising that the CaM-inhibitory peptide had
no effect on Ca2+-dependent current run-down in our
experiments. Furthermore, our data suggest that neither
calcineurin nor alpha-actinin-cytoskeletal interactions
mediate Ca2+ dependent rundown. In SNc dopaminergic
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neurones, other Ca2+ dependent molecules, such as
gelsonlin, may be important (Furukawa et al., 1997).
Whole-cell NMDAR current run-down is greater in SNr
than in SNc
Nigrostriatal dopaminergic neurones are known to
degenerate in Parkinson’s disease, while GABAergic
neurones of the SNr are much less affected (Braak et al.
2003). The changes in the circuitry of the basal ganglia
that occur following nigrostriatal degeneration include
an increase in activity of the subthalamic nucleus, which
is a major source of glutamatergic input to both the
SNc and the SNr (Hamani et al. 2004; Watabe-Uchida
et al. 2012). This enhanced excitatory input is hypo-
thesized to contribute to excitotoxic neuronal damage
to dopaminergic neurones in Parkinson’s disease (Piallat
et al. 1996, 1999; Bezard et al. 1999). If this alone were
the pathological trigger, then GABAergic neurones might
also be vulnerable, but pathological changes such as
mitochondrial dysfunction and an increase in reactive
oxygen species might enhance excitotoxicity in a way
that is unique to dopaminergic neurones in Parkinson’s
disease (reviewed by Schapira, 2008; Surmeier et al. 2010).
Consistent with our previous work (Sua´rez et al. 2010), in
these experiments NMDAR current run-downwas greater
in SNr GABAergic neurones than in SNc dopaminergic
neurones with BAPTA in the pipette solution. It is possible
that differences in regulatory mechanisms exist between
the two neuronal populations, such as differences in
Ca2+-binding proteins or receptor trafficking pathways.
As run-down may be a protective mechanism to limit
excessive Ca2+ influx during periods of high activity
(Hashimoto et al. 2002), the more pronounced run-down
in SNr GABAergic neurones might reflect a more robust
protective response. This may in turn affect the sensitivity
of the two neuronal populations to excitotoxic stress
caused by enhanced glutamatergic input from the sub-
thalamic nucleus in Parkinson’s disease (Hamani et al.
2004).
In the present study, we investigated the regulatory
mechanisms present in dopaminergic neurones using rats
aged 7 days postnatal as a model system. Our pre-
vious pharmacology experiments suggested only small
changes in NMDA receptor subunit composition between
postnatal days 7 and 28, because the proportions of
both synaptic current and whole-cell NMDA current
blocked by ifenprodil are quite similar between post-
natal days 7 and 28 (Brothwell et al. 2008; Sua´rez et al.
2010). This suggestion agrees well with the results of
earlier biochemical experiments showing that receptor
subunit expression in the developing and adult rat mid-
brain is dominated by GluN2B and GluN2D (Monyer
et al. 1994; Dunah et al. 1996; Wenzel et al. 1996). A
more subtle question is whether, in mature rats, the
proportion of triheteromeric GluN1/GluN2B/GluN2D
receptors (Dunah et al. 1998) is significantly different from
that early in development.More selective pharmacological
tools are needed to address this question. However,
it would be interesting to investigate whether similar
mechanisms of NMDA receptor run-down are apparent
in ageing rats and in rodent models of Parkinson’s disease.
Calcium-independent regulation of whole-cell
NMDAR current run-down
The persistence of a small degree of whole-cell current
run-down in conditions where Ca2+ influx was mini-
mized suggested that, like NMDARs in hippocampal
neurones (Vissel et al. 2001; Li et al. 2002), those in
SNc dopaminergic neurones might also be regulated by
Ca2+-independentmechanisms. A change in peak current
was observed when ion flux through the receptor was
blocked with Mg2+, suggesting that a reduction in the
surface expression of NMDARs, independent of ion flux,
may occur in SNc dopaminergic neurones; these receptors
are composed of GluN2B and GluN2D subunits (Dunah
et al. 1998; Jones & Gibb, 2005; Brothwell et al. 2008;
Sua´rez et al. 2010). Endocytosis of GluN2B-containing
receptors has been studied extensively and is regulated
by phosphorylation of a tyrosine residue found in the
YEKL motif at the distal end of the C-terminal region
(Roche et al. 2001; Lavezzari et al. 2004; Scott et al.
2004; Prybylowski et al. 2005; Zhang et al. 2008). It
seems plausible that GluN2B-containing receptors in
SNc dopaminergic neurones are partly regulated in a
Ca2+-independent, activity-dependentmanner thatmight
reflect changes in tyrosine phosphorylation and receptor
surface expression. However, glycine ‘priming’ of this
mechanism, as seen in hippocampal neurones (Nong et al.
2003), was not observed in dopamine neurons (Fig. 6G).
Activity-dependent changes in NMDAR trafficking in
SNc dopaminergic neurones were further substantiated by
the reduction in current run-down during intracellular
dialysis with a dynamin-inhibitory peptide, suggesting
that run-down is in part due to removal of NMDARs
from the neuronal membrane. This is consistent with
previous findings that GluN2B-containing receptors are
internalized by clathrin-mediated endocytosis (Roche
et al. 2001; Lavezzari et al. 2004; Scott et al. 2004;
Prybylowski et al. 2005; Zhang et al. 2008) and that
internalization can be regulated in an activity-dependent
manner (Vissel et al. 2001; Li et al. 2002).
Regulation of synaptic NMDAR current run-down
The strength of synaptic NMDAR signalling can also
be regulated in a Ca2+-dependent manner in cultured
hippocampal (Rosenmund et al. 1995; Tong et al.
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1995; Mennerick & Zorumski, 1996; Medina et al.
1999) and cortical neurones (Umemiya et al. 2001).
Repeated low-frequency stimulation of autaptic cultured
hippocampal neurones decreased the amplitude ofNMDA
EPSCs in a Ca2+-dependent manner (Rosenmund et al.
1995), and the decay kinetics of miniature NMDA EPSCs
was altered by intracellular perfusion with BAPTA but not
EGTA (Umemiya et al. 2001).
In the data presented here, NMDA synaptic current
run-down was observed in response to repeated
low-frequency synaptic stimulation (0.1 Hz) in neuro-
nes voltage clamped to −50 mV (Fig. 3). This was not
altered by changing the strength of intracellular Ca2+
buffering (i.e. replacing 0.6 mM EGTA with 10 mM
BAPTA), but run-down was significantly reduced by
clamping neurones to +40 mV, which reduces the driving
force for Ca2+ influx. The lack of sensitivity of synaptic
NMDAR current run-down to the Ca2+ chelators, BAPTA
versus EGTA, in contrast to whole-cell NMDAR current
run-down, may be due to themode of NMDAR activation
(rapid and brief versus slower and more prolonged) or
due to a much closer coupling of the Ca2+-dependent
mechanism of run-down to synaptic NMDARs, such that
even the fast chelator BAPTA is not able to sequester
the rapid Ca2+ influx effectively through the synaptic
NMDARs.
In cultured hippocampal neurons, trafficking of
synaptic and extrasynaptic NMDARs is differentially
regulated, with synaptic receptors being less sensitive
to internalization than their extrasynaptic counterparts
(Li et al. 2002). The NMDA EPSCs in dopamine
neurons were not affected by intracellular dialysis with
a dynamin-inhibitory peptide, suggesting there is little
receptor internalization in these conditions. The stability
of synaptic NMDARs in other neuronal populations is
attributed to association with scaffolding molecules, such
as PSD-95, in the postsynaptic density (Rao et al. 1998;
Roche et al. 2001; Lim et al. 2003; Prybylowski et al.
2005; Groc et al. 2009) and association with tyrosine
kinases (Goebel-Goody et al. 2009), both of which inhibit
NMDAR endocytosis (Lavezzari et al. 2003). It may be
that synaptic NMDARs in SNc dopaminergic neurones
also form a stable receptor pool.
In summary, NMDARs in SNc dopaminergic neuro-
nes are robustly regulated in an activity-dependent
manner. Evidence has been presented here for both
Ca2+-dependent run-down of synaptic and whole-cell
NMDAR currents and Ca2+-independent changes in
whole-cell receptor trafficking. These mechanisms
may contribute to intracellular Ca2+ homeostasis in
dopaminergic neurones by limiting Ca2+ influx through
the NMDAR and are therefore a possible mechanism of
dysregulation in Parkinson’s disease.
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